Risperidone: review of its pharmacology and therapeutic use in schizophrenia

Ann Clin Psychiatry. 1994 Sep;6(3):173-80. doi: 10.3109/10401239409149000.

Abstract

The discovery of antipsychotic medications has revolutionized the treatment of schizophrenia and other psychotic disorders. However, side effects such as extrapyramidal symptoms (EPS) and tardive dyskinesia have been limiting factors in treatment. The introduction of atypical drugs such as clozapine and risperidone has ushered in a new era. This article provides an overview of the pharmacology, efficacy, and techniques for the clinical use of risperidone, which has recently become available.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antipsychotic Agents / pharmacology
  • Antipsychotic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Isoxazoles / pharmacokinetics
  • Isoxazoles / pharmacology
  • Isoxazoles / therapeutic use*
  • Piperidines / pharmacokinetics
  • Piperidines / pharmacology
  • Piperidines / therapeutic use*
  • Placebos
  • Risperidone
  • Schizophrenia / drug therapy*
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Isoxazoles
  • Piperidines
  • Placebos
  • Risperidone